Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants.

scientific article

Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/AJT.14415
P932PMC publication ID5662482
P698PubMed publication ID28675676

P50authorJoshua YangQ58136758
Sindhu ChandranQ88445343
P2093author name stringJ A Bluestone
Q Tang
M Fitch
K Lee
J Leung
T Sigdel
V Nguyen
F Vincenti
M Hellerstein
M Sarwal
Z G Laszik
E C Tavares
A L Putnam
P2860cites workRegulatory T-cell therapy in transplantation: moving to the clinicQ27025869
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantationQ34162461
Fibrosis with inflammation at one year predicts transplant functional decline.Q34457101
Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transferQ34536661
Messenger RNA for FOXP3 in the urine of renal-allograft recipientsQ34563002
Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region.Q35252405
Central Role of CD45RA- Foxp3hi Memory Regulatory T Cells in Clinical Kidney Transplantation ToleranceQ35903107
Tolerant Kidney Transplant Patients Produce B Cells with Regulatory PropertiesQ36104784
Subclinical inflammation and chronic renal allograft injury in a randomized trial on steroid avoidance in pediatric kidney transplantationQ36281955
Type 1 diabetes immunotherapy using polyclonal regulatory T cellsQ36509805
CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospectsQ36826059
A mechanism for expansion of regulatory T-cell repertoire and its role in self-toleranceQ36888933
Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts.Q36906015
The Foxp3+ regulatory T cell: a jack of all trades, master of regulationQ37088900
Expansion of human regulatory T-cells from patients with type 1 diabetesQ37105331
Regulatory T cells in kidney disease and transplantationQ38855295
Isolation, expansion and functional assessment of CD4+CD25+FoxP3+ regulatory T cells and Tr1 cells from uremic patients awaiting kidney transplantationQ39702510
Ex Vivo Costimulatory Blockade to Generate Regulatory T Cells From Patients Awaiting Kidney Transplantation.Q40083199
Banff 07 classification of renal allograft pathology: updates and future directionsQ40121163
Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritisQ44688981
Natural history, risk factors, and impact of subclinical rejection in kidney transplantationQ44997881
Identifying specific causes of kidney allograft loss.Q45810388
Impact of subclinical inflammation on the development of interstitial fibrosis and tubular atrophy in kidney transplant recipientsQ50073303
A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation.Q52888768
The Banff 97 working classification of renal allograft pathologyQ59314413
Subclinical Rejection Associated with Chronic Allograft Nephropathy in Protocol Biopsies as a Risk Factor for Late Graft LossQ62619830
Functionally significant renal allograft rejection is defined by transcriptional criteriaQ81395033
Regulatory T cells in kidney allograft infiltrates correlate with initial inflammation and graft functionQ82632541
Long-term impact of subclinical inflammation diagnosed by protocol biopsy one year after renal transplantationQ84870290
Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-upQ87620046
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectinflammationQ101991
P304page(s)2945-2954
P577publication date2017-08-14
P1433published inAmerican Journal of TransplantationQ4744273
P1476titlePolyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants
P478volume17

Reverse relations

cites work (P2860)
Q54216691A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants.
Q88663316Contemporary Strategies and Barriers to Transplantation Tolerance
Q104264527Cross talk between human regulatory T cells and antigen presenting cells: Lessons for clinical applications
Q49829282Current Status of Gene Engineering Cell Therapeutics
Q100316586Functional CRISPR dissection of gene networks controlling human regulatory T cell identity
Q90529882Generation and functional assessment of nonhuman primate regulatory dendritic cells and their therapeutic efficacy in renal transplantation
Q47138817Good Manufacturing Practice-Compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients with Autoimmune and Inflammatory Disorders
Q52732932HLA variation and disease.
Q58105822High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
Q95645095Kidney transplantation: a safe step forward for regulatory immune cell therapy
Q49403463Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization
Q90197782Next-generation regulatory T cell therapy
Q64236635Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity
Q97519150Progress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies
Q88777827Regulatory T Cells and Kidney Transplantation
Q50319201Regulatory T cells in renal disease.
Q89910768Regulatory T cells in solid organ transplantation
Q95645109Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
Q93004973Semaphorin 4A Stabilizes Human Regulatory T Cell Phenotype via Plexin B1
Q98465729The Future of Regulatory T Cell Therapy: Promises and Challenges of Implementing CAR Technology
Q57816711Tolerance Induction in Relation to the Eye
Q61805676Transient increase of activated regulatory T cells early after kidney transplantation
Q50321579Vitamin C Fosters the In Vivo Differentiation of Peripheral CD4+ Foxp3- T Cells into CD4+ Foxp3+ Regulatory T Cells but Impairs Their Ability to Prolong Skin Allograft Survival.
Q64110642Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective

Search more.